Cargando…
Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma
BACKGROUND: Monocarboxylate transporter 4 (MCT4) is a critical element for glycolytic metabolism and malignant behaviors in many tumor cells. This study aimed to determine the expression level of MCT4 protein and its prognostic value in osteosarcoma. MATERIAL/METHODS: MCT4 expression was detected vi...
Autores principales: | Liu, Yannan, Sun, Xuanwu, Huo, Chunguang, Sun, Chu, Zhu, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582689/ https://www.ncbi.nlm.nih.gov/pubmed/31177263 http://dx.doi.org/10.12659/MSM.912272 |
Ejemplares similares
-
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011) -
High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2021) -
Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer
por: Tan, Wenlong, et al.
Publicado: (2017) -
Overexpression of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Is Correlated with Clinical Progression and Poor Prognosis in Breast Cancer
por: Yi, Hua, et al.
Publicado: (2018) -
Inhibition of monocarboxylate transporters (MCT) 1 and 4 reduces exercise capacity in mice
por: Kitaoka, Yu, et al.
Publicado: (2022)